Sartorius AG Xetra

Equities

SRT

DE0007165607

Advanced Medical Equipment & Technology

Real-time Estimate Tradegate 09:36:26 2024-03-28 am EDT 5-day change 1st Jan Change
273 EUR +1.11% Intraday chart for Sartorius AG -4.55% +2.83%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
SARTORIUS VORZUEGE : Barclays reaffirms its Neutral rating ZD
SARTORIUS VORZUEGE : JP Morgan maintains a Buy rating ZD
SARTORIUS VORZUEGE : Jefferies sticks Neutral ZD
Stifel reinstates Sartorius with 'Buy' - target 415 euros DP
SARTORIUS VORZUEGE : UBS reiterates its Neutral rating ZD
SARTORIUS VORZUEGE : Jefferies sticks Neutral ZD
Jefferies raises target for Sartorius to 359 euros - 'Hold' DP
SARTORIUS VORZUEGE : Barclays remains Neutral ZD
Sartorius falls - outlook from Repligen disappointed DP
Warburg Research raises target for Sartorius to 320 euros - 'Hold' DP
SARTORIUS VORZUEGE : Warburg Research remains Neutral ZD
Deutsche Bank Research lowers target for Sartorius - 'Hold' DP
Sartorius Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2023 CI
SARTORIUS VORZUEGE : Deutsche Bank reaffirms its Neutral rating ZD
Berenberg raises target for Sartorius to 346 euros - 'Buy' DP
SARTORIUS VORZUEGE : Berenberg gives a Buy rating ZD
Sartorius gains despite halving dividend DP
Sartorius Board Proposes Lower FY23 Dividend MT
Sartorius to halve dividend DP
SARTORIUS VORZUEGE : Barclays reaffirms its Neutral rating ZD
SARTORIUS VORZUEGE : Warburg Research remains Neutral ZD
SARTORIUS VORZUEGE : Jefferies reiterates its Neutral rating ZD
Debt reduction: Sartorius sells shares - Stedim with capital increase DP
Germany's Sartorius Raises EUR200 Million Via Share Issue MT
Sartorius Stedim Biotech Raises EUR1.2 Billion in Fresh Capital from Share Sale MT
Chart Sartorius AG
More charts
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates through two segments: Bioprocess Solutions and Lab Products and Services. The Bioprocess Solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, and filter technology for clarification, among others. The Lab Products and Services segment provides instruments, consumables and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation and membrane filter systems for sterility testing of parenterals.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
364 EUR
Average target price
349.8 EUR
Spread / Average Target
-3.91%
Consensus